The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects

Gastric cancer remains a significant health burden globally, especially prevalent in Asian and European regions. Despite a notable decline in incidence in the United States and Western Europe over recent decades, the disease's persistence underscores the urgency for advanced research in its pat...

Full description

Saved in:
Bibliographic Details
Published inJournal of translational medicine Vol. 22; no. 1; pp. 1142 - 18
Main Authors Yuan, Weiwei, Shi, Yin, Dai, Shiping, Deng, Mao, Zhu, Kai, Xu, Yuanmin, Chen, Zhangming, Xu, Zhou, Zhang, Tianlong, Liang, Song
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 24.12.2024
BioMed Central
BMC
Subjects
Analysis
Animals
Care and treatment
Diagnosis
Extracellular signal-regulated kinases
Gastric carcinogenesis
H. pylori and EBV-induced oncogenesis
Health aspects
Humans
MAP Kinase Signaling System
MicroRNAs - genetics
MicroRNAs - metabolism
miRNAs and lncRNAs
Mitogen-activated protein kinase signaling
Molecular dynamics
Review
Stomach cancer
Stomach Neoplasms - genetics
Stomach Neoplasms - metabolism
Stomach Neoplasms - pathology
Stomach Neoplasms - therapy
Targeted therapy and molecular inhibitors
China
Gastric carcinogenesis
miRNAs and lncRNAs
Targeted therapy and molecular inhibitors
Mitogen-activated protein kinase signaling
H. pylori and EBV-induced oncogenesis
Online AccessGet full text

Cover

Abstract Gastric cancer remains a significant health burden globally, especially prevalent in Asian and European regions. Despite a notable decline in incidence in the United States and Western Europe over recent decades, the disease's persistence underscores the urgency for advanced research in its pathogenesis and treatment strategies. Central to this pursuit is the exploration of the mitogen-activated protein kinase (MAPK) pathway, a pivotal cellular mechanism implicated in the complex processes of gastric cancer development, including cellular proliferation, invasion, migration, and metastasis. The MAPK or extracellular signal-regulated kinase pathway serves as a crucial conduit for transmitting extracellular signals to elicit intracellular responses, with its signaling cascades subject to alterations due to genetic and epigenetic variations across various diseases, prominently cancer. This review delves into the intricate role of the MAPK signaling pathway in the pathogenesis of gastric cancer, drawing upon the most recent and critical studies that shed light on MAPK pathway alterations as a gateway to the disease. It highlights the pathway's involvement in Helicobacter pylori-mediated gastric carcinogenesis and the tumorigenic processes induced by the Epstein-Barr virus, showcasing the substantial influence of miRNAs and lncRNAs in modulating gastric cancer's biological properties through their interaction with the MAPK pathway. Furthermore, the review extends into the therapeutic arena, discussing the promising impacts of herbal medicines, MAPK pathway inhibitors, and immunosuppressants on mitigating gastric cancer's progression. Through an exhaustive examination of the MAPK pathway's multifaceted role in gastric cancer, from molecular crosstalks to therapeutic prospects, this review aspires to contribute to the ongoing efforts in understanding and combating this global health challenge, paving the way for novel therapeutic interventions and improved patient outcomes.
AbstractList Gastric cancer remains a significant health burden globally, especially prevalent in Asian and European regions. Despite a notable decline in incidence in the United States and Western Europe over recent decades, the disease's persistence underscores the urgency for advanced research in its pathogenesis and treatment strategies. Central to this pursuit is the exploration of the mitogen-activated protein kinase (MAPK) pathway, a pivotal cellular mechanism implicated in the complex processes of gastric cancer development, including cellular proliferation, invasion, migration, and metastasis. The MAPK or extracellular signal-regulated kinase pathway serves as a crucial conduit for transmitting extracellular signals to elicit intracellular responses, with its signaling cascades subject to alterations due to genetic and epigenetic variations across various diseases, prominently cancer. This review delves into the intricate role of the MAPK signaling pathway in the pathogenesis of gastric cancer, drawing upon the most recent and critical studies that shed light on MAPK pathway alterations as a gateway to the disease. It highlights the pathway's involvement in Helicobacter pylori-mediated gastric carcinogenesis and the tumorigenic processes induced by the Epstein-Barr virus, showcasing the substantial influence of miRNAs and lncRNAs in modulating gastric cancer's biological properties through their interaction with the MAPK pathway. Furthermore, the review extends into the therapeutic arena, discussing the promising impacts of herbal medicines, MAPK pathway inhibitors, and immunosuppressants on mitigating gastric cancer's progression. Through an exhaustive examination of the MAPK pathway's multifaceted role in gastric cancer, from molecular crosstalks to therapeutic prospects, this review aspires to contribute to the ongoing efforts in understanding and combating this global health challenge, paving the way for novel therapeutic interventions and improved patient outcomes. Keywords: Gastric carcinogenesis, Mitogen-activated protein kinase signaling, H.pylori and EBV-induced oncogenesis, miRNAs and lncRNAs, Targeted therapy and molecular inhibitors
Gastric cancer remains a significant health burden globally, especially prevalent in Asian and European regions. Despite a notable decline in incidence in the United States and Western Europe over recent decades, the disease’s persistence underscores the urgency for advanced research in its pathogenesis and treatment strategies. Central to this pursuit is the exploration of the mitogen-activated protein kinase (MAPK) pathway, a pivotal cellular mechanism implicated in the complex processes of gastric cancer development, including cellular proliferation, invasion, migration, and metastasis. The MAPK or extracellular signal-regulated kinase pathway serves as a crucial conduit for transmitting extracellular signals to elicit intracellular responses, with its signaling cascades subject to alterations due to genetic and epigenetic variations across various diseases, prominently cancer. This review delves into the intricate role of the MAPK signaling pathway in the pathogenesis of gastric cancer, drawing upon the most recent and critical studies that shed light on MAPK pathway alterations as a gateway to the disease. It highlights the pathway’s involvement in Helicobacter pylori -mediated gastric carcinogenesis and the tumorigenic processes induced by the Epstein-Barr virus, showcasing the substantial influence of miRNAs and lncRNAs in modulating gastric cancer’s biological properties through their interaction with the MAPK pathway. Furthermore, the review extends into the therapeutic arena, discussing the promising impacts of herbal medicines, MAPK pathway inhibitors, and immunosuppressants on mitigating gastric cancer’s progression. Through an exhaustive examination of the MAPK pathway’s multifaceted role in gastric cancer, from molecular crosstalks to therapeutic prospects, this review aspires to contribute to the ongoing efforts in understanding and combating this global health challenge, paving the way for novel therapeutic interventions and improved patient outcomes.
Gastric cancer remains a significant health burden globally, especially prevalent in Asian and European regions. Despite a notable decline in incidence in the United States and Western Europe over recent decades, the disease's persistence underscores the urgency for advanced research in its pathogenesis and treatment strategies. Central to this pursuit is the exploration of the mitogen-activated protein kinase (MAPK) pathway, a pivotal cellular mechanism implicated in the complex processes of gastric cancer development, including cellular proliferation, invasion, migration, and metastasis. The MAPK or extracellular signal-regulated kinase pathway serves as a crucial conduit for transmitting extracellular signals to elicit intracellular responses, with its signaling cascades subject to alterations due to genetic and epigenetic variations across various diseases, prominently cancer. This review delves into the intricate role of the MAPK signaling pathway in the pathogenesis of gastric cancer, drawing upon the most recent and critical studies that shed light on MAPK pathway alterations as a gateway to the disease. It highlights the pathway's involvement in Helicobacter pylori-mediated gastric carcinogenesis and the tumorigenic processes induced by the Epstein-Barr virus, showcasing the substantial influence of miRNAs and lncRNAs in modulating gastric cancer's biological properties through their interaction with the MAPK pathway. Furthermore, the review extends into the therapeutic arena, discussing the promising impacts of herbal medicines, MAPK pathway inhibitors, and immunosuppressants on mitigating gastric cancer's progression. Through an exhaustive examination of the MAPK pathway's multifaceted role in gastric cancer, from molecular crosstalks to therapeutic prospects, this review aspires to contribute to the ongoing efforts in understanding and combating this global health challenge, paving the way for novel therapeutic interventions and improved patient outcomes.
Abstract Gastric cancer remains a significant health burden globally, especially prevalent in Asian and European regions. Despite a notable decline in incidence in the United States and Western Europe over recent decades, the disease’s persistence underscores the urgency for advanced research in its pathogenesis and treatment strategies. Central to this pursuit is the exploration of the mitogen-activated protein kinase (MAPK) pathway, a pivotal cellular mechanism implicated in the complex processes of gastric cancer development, including cellular proliferation, invasion, migration, and metastasis. The MAPK or extracellular signal-regulated kinase pathway serves as a crucial conduit for transmitting extracellular signals to elicit intracellular responses, with its signaling cascades subject to alterations due to genetic and epigenetic variations across various diseases, prominently cancer. This review delves into the intricate role of the MAPK signaling pathway in the pathogenesis of gastric cancer, drawing upon the most recent and critical studies that shed light on MAPK pathway alterations as a gateway to the disease. It highlights the pathway’s involvement in Helicobacter pylori-mediated gastric carcinogenesis and the tumorigenic processes induced by the Epstein-Barr virus, showcasing the substantial influence of miRNAs and lncRNAs in modulating gastric cancer’s biological properties through their interaction with the MAPK pathway. Furthermore, the review extends into the therapeutic arena, discussing the promising impacts of herbal medicines, MAPK pathway inhibitors, and immunosuppressants on mitigating gastric cancer’s progression. Through an exhaustive examination of the MAPK pathway’s multifaceted role in gastric cancer, from molecular crosstalks to therapeutic prospects, this review aspires to contribute to the ongoing efforts in understanding and combating this global health challenge, paving the way for novel therapeutic interventions and improved patient outcomes.
Gastric cancer remains a significant health burden globally, especially prevalent in Asian and European regions. Despite a notable decline in incidence in the United States and Western Europe over recent decades, the disease's persistence underscores the urgency for advanced research in its pathogenesis and treatment strategies. Central to this pursuit is the exploration of the mitogen-activated protein kinase (MAPK) pathway, a pivotal cellular mechanism implicated in the complex processes of gastric cancer development, including cellular proliferation, invasion, migration, and metastasis. The MAPK or extracellular signal-regulated kinase pathway serves as a crucial conduit for transmitting extracellular signals to elicit intracellular responses, with its signaling cascades subject to alterations due to genetic and epigenetic variations across various diseases, prominently cancer. This review delves into the intricate role of the MAPK signaling pathway in the pathogenesis of gastric cancer, drawing upon the most recent and critical studies that shed light on MAPK pathway alterations as a gateway to the disease. It highlights the pathway's involvement in Helicobacter pylori-mediated gastric carcinogenesis and the tumorigenic processes induced by the Epstein-Barr virus, showcasing the substantial influence of miRNAs and lncRNAs in modulating gastric cancer's biological properties through their interaction with the MAPK pathway. Furthermore, the review extends into the therapeutic arena, discussing the promising impacts of herbal medicines, MAPK pathway inhibitors, and immunosuppressants on mitigating gastric cancer's progression. Through an exhaustive examination of the MAPK pathway's multifaceted role in gastric cancer, from molecular crosstalks to therapeutic prospects, this review aspires to contribute to the ongoing efforts in understanding and combating this global health challenge, paving the way for novel therapeutic interventions and improved patient outcomes.Gastric cancer remains a significant health burden globally, especially prevalent in Asian and European regions. Despite a notable decline in incidence in the United States and Western Europe over recent decades, the disease's persistence underscores the urgency for advanced research in its pathogenesis and treatment strategies. Central to this pursuit is the exploration of the mitogen-activated protein kinase (MAPK) pathway, a pivotal cellular mechanism implicated in the complex processes of gastric cancer development, including cellular proliferation, invasion, migration, and metastasis. The MAPK or extracellular signal-regulated kinase pathway serves as a crucial conduit for transmitting extracellular signals to elicit intracellular responses, with its signaling cascades subject to alterations due to genetic and epigenetic variations across various diseases, prominently cancer. This review delves into the intricate role of the MAPK signaling pathway in the pathogenesis of gastric cancer, drawing upon the most recent and critical studies that shed light on MAPK pathway alterations as a gateway to the disease. It highlights the pathway's involvement in Helicobacter pylori-mediated gastric carcinogenesis and the tumorigenic processes induced by the Epstein-Barr virus, showcasing the substantial influence of miRNAs and lncRNAs in modulating gastric cancer's biological properties through their interaction with the MAPK pathway. Furthermore, the review extends into the therapeutic arena, discussing the promising impacts of herbal medicines, MAPK pathway inhibitors, and immunosuppressants on mitigating gastric cancer's progression. Through an exhaustive examination of the MAPK pathway's multifaceted role in gastric cancer, from molecular crosstalks to therapeutic prospects, this review aspires to contribute to the ongoing efforts in understanding and combating this global health challenge, paving the way for novel therapeutic interventions and improved patient outcomes.
ArticleNumber 1142
Audience Academic
Author Liang, Song
Shi, Yin
Xu, Zhou
Yuan, Weiwei
Xu, Yuanmin
Zhu, Kai
Chen, Zhangming
Deng, Mao
Dai, Shiping
Zhang, Tianlong
Author_xml – sequence: 1
  givenname: Weiwei
  orcidid: 0009-0004-2686-6918
  surname: Yuan
  fullname: Yuan, Weiwei
– sequence: 2
  givenname: Yin
  surname: Shi
  fullname: Shi, Yin
– sequence: 3
  givenname: Shiping
  surname: Dai
  fullname: Dai, Shiping
– sequence: 4
  givenname: Mao
  surname: Deng
  fullname: Deng, Mao
– sequence: 5
  givenname: Kai
  surname: Zhu
  fullname: Zhu, Kai
– sequence: 6
  givenname: Yuanmin
  surname: Xu
  fullname: Xu, Yuanmin
– sequence: 7
  givenname: Zhangming
  surname: Chen
  fullname: Chen, Zhangming
– sequence: 8
  givenname: Zhou
  surname: Xu
  fullname: Xu, Zhou
– sequence: 9
  givenname: Tianlong
  surname: Zhang
  fullname: Zhang, Tianlong
– sequence: 10
  givenname: Song
  orcidid: 0000-0002-8211-6554
  surname: Liang
  fullname: Liang, Song
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39719645$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhSNURB_wB1ggS2y6SbGd-MUGjSoKFUWwKGvLvrFnXDJ2cJKi_vt6ZkrVQQh5Yeve7xxd2-e4Oogpuqp6TfAZIZK_GwlVXNSYtjVmSslaPquOSCtUzaTgB0_Oh9XxON7gQrJWvagOGyWI4i07quB65VBOvUPJo6-L71_QYKbVb3OHQkRLM045AAITweX3aI63LvQhLtG6KGDuTUaQ0zhOpv-JTOzQtHLZDG6eimooncHBNL6snnvTj-7Vw35S_bj4eH3-ub769unyfHFVA2v4VDfQSADlvaOYWWKFl55QD52k2FrgjfeUM89YB0pYMI452Xams6Ba7hranFSXO98umRs95LA2-U4nE_S2kPJSm1wm650mVlIlLRWNwC3HwnTCg2wxttIAMbZ4fdh5DbNduw5cnLLp90z3OzGs9DLdakI4F0rx4nD64JDTr9mNk16HEVzfm-jSPOqGtAoLjFtc0Lc7dGnKbCH6VCxhg-uFpIRSyYQo1Nk_qLI6tw5QouFDqe8J3jy9w-Pwf36_AHQHbD8xO_-IEKw3EdO7iOkSHL2NmJZFJP8SQZjMFNLmHUL_P-k9SwTWvQ
CitedBy_id crossref_primary_10_3390_ijms26062667
Cites_doi 10.1038/sj.bjp.0703534
10.1080/13543776.2020.1749263
10.1093/ije/dyw078
10.1016/j.canlet.2016.12.033
10.1371/journal.pone.0100893
10.1142/S0192415X21500245
10.1038/s41401-023-01165-9
10.1128/MMBR.00031-10
10.1016/j.phrs.2022.106440
10.18632/aging.203484
10.1038/cddis.2017.205
10.6004/jnccn.2022.0008
10.3322/caac.21660
10.5334/aogh.2570
10.1186/s12935-021-01793-3
10.1038/s41375-021-01472-2
10.1038/cddis.2017.5
10.1128/jvi.00881-23
10.1136/gutjnl-2019-319696
10.3390/cancers13143540
10.1016/j.jep.2024.118538
10.1016/j.cell.2009.06.044
10.1186/s11658-019-0178-5
10.1074/jbc.M110.115824
10.3748/wjg.v21.i4.1305
10.1016/j.chom.2009.03.004
10.1007/s11864-021-00884-7
10.1053/j.gastro.2022.01.046
10.1083/jcb.202009045
10.1136/gutjnl-2021-325948
10.1186/s12943-022-01702-w
10.1053/j.gastro.2023.12.022
10.1016/j.gpb.2017.06.002
10.1186/s12864-022-08578-6
10.1631/jzus.B2100182
10.1007/s00432-022-04408-0
10.1016/j.biopha.2017.10.066
10.3389/fphar.2023.1282203
10.1007/s00705-024-06033-3
10.3390/ijms21072531
10.1016/S0305-7372(10)70014-1
10.1158/0008-5472.CAN-09-4531
10.1016/j.cell.2022.08.026
10.1038/s41572-023-00431-8
10.1016/j.semcancer.2012.01.004
10.1016/j.lfs.2018.07.032
10.3748/wjg.v19.i45.8188
10.1038/s41591-018-0022-x
10.1158/1078-0432.CCR-18-2804
10.1016/j.cell.2005.01.014
10.1002/jcb.27542
10.1080/1061186X.2019.1648477
10.15252/emmm.202215705
10.1161/hh2101.099504
10.21873/invivo.11126
10.1093/annonc/mdw040
10.1146/annurev-biochem-081720-114505
10.18632/oncotarget.15675
10.1038/cddis.2016.13
10.1038/s41598-021-94576-9
10.3389/fcell.2021.689992
10.1053/j.gastro.2023.08.028
10.1016/j.freeradbiomed.2016.10.495
10.2478/s11658-008-0045-2
10.1186/s12879-017-2412-y
10.1177/1534735420953215
10.1038/s41423-019-0339-5
10.1053/j.gastro.2015.09.004
10.1097/MCG.0000000000001719
10.1016/j.canlet.2020.09.019
10.1016/j.yexcr.2021.112956
10.1016/j.apsb.2020.07.010
10.1111/cpr.12252
10.1016/j.ccell.2020.03.013
10.1038/s41571-023-00747-0
10.1038/s41571-019-0268-3
10.1016/j.molcel.2022.05.027
10.1055/a-2041-2986
10.1186/s12885-017-3949-2
10.1128/mBio.00589-20
10.2147/OTT.S168819
10.1038/s41392-023-01406-7
10.1080/21655979.2021.1889109
10.1016/j.chom.2023.06.016
10.1038/nature13480
10.1016/j.critrevonc.2012.08.008
10.3390/ijms21082893
10.1126/scitranslmed.3001539
10.2147/CMAR.S186002
10.1155/2016/4819423
10.1007/s13402-022-00715-3
10.1093/jjco/hyt166
10.1038/s41419-020-03049-w
10.1016/j.ccr.2010.08.013
10.1186/s13046-022-02588-8
10.1021/acs.jmedchem.2c01244
10.1128/IAI.68.8.4378-4383.2000
10.1016/j.tim.2020.02.004
10.1186/s13073-021-00963-2
10.1093/carcin/bgq013
10.1038/s41591-018-0101-z
10.1186/s12943-017-0727-3
10.1016/j.bpg.2006.11.002
10.1056/NEJMoa2211807
10.3892/ijo.2021.5187
10.1038/s41388-020-01610-7
10.3390/toxins10040163
10.3892/ijo.2014.2252
10.1186/s13046-023-02827-6
10.1186/1476-4598-13-68
10.1038/s41419-021-04396-y
10.1186/s12943-021-01475-8
10.1016/j.apsb.2021.12.022
10.1186/s12903-018-0541-3
10.1515/med-2023-0776
10.3390/ijms21218307
10.1038/s41401-020-00540-0
10.1016/j.biopha.2021.111876
10.1097/CM9.0000000000000742
10.6004/jnccn.2016.0138
10.1002/cam4.818
10.1053/j.gastro.2023.09.040
10.1136/gutjnl-2020-322368
10.1016/S1097-2765(02)00681-0
10.1002/ptr.7652
10.1002/iub.2259
10.1016/j.biopha.2016.03.046
10.1016/j.canlet.2022.215764
10.3390/cancers13215451
10.1093/carcin/bgac018
10.2147/OTT.S217452
10.1038/s41419-018-0611-0
10.3389/fimmu.2023.1183331
10.3390/ijms21051782
10.1016/j.cellsig.2022.110286
10.1016/j.biopha.2020.110245
10.3390/microorganisms12010222
10.3892/mmr.2016.5361
10.1016/j.gene.2020.144937
10.3390/nu16070965
10.1155/2014/352371
10.1080/19490976.2021.1909459
10.2217/fon-2022-0574
10.1007/s43440-021-00238-y
10.1080/19490976.2022.2089003
10.1111/cyt.12053
10.1038/s41571-023-00767-w
10.1002/ijc.30816
10.1016/j.critrevonc.2022.103841
10.1158/1078-0432.CCR-13-1549
10.1159/000538349
10.1017/erm.2017.4
10.1016/S1470-2045(20)30460-5
10.1080/15384047.2022.2038002
10.1186/s12943-021-01451-2
10.1016/j.jep.2024.117988
10.3390/ijms231911990
10.1053/j.gastro.2023.01.018
10.1080/17474124.2021.1845140
10.1016/j.cell.2022.09.015
10.1111/jipb.13215
10.1111/jcmm.13661
10.1016/j.omtn.2018.05.009
10.7150/thno.16044
10.1038/s41417-023-00622-1
10.1016/j.ejmech.2020.113006
10.1016/j.ejmech.2021.113473
10.1016/j.biopha.2021.112235
10.3390/ijms25031848
10.3748/wjg.v20.i36.12847
10.3390/jcm12103391
ContentType Journal Article
Copyright 2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
The Author(s) 2024 2024
Copyright_xml – notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: The Author(s) 2024 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1186/s12967-024-05998-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1479-5876
EndPage 18
ExternalDocumentID oai_doaj_org_article_1b8298b273704607ad7fc8400b8ac1ab
PMC11667996
A821228577
39719645
10_1186_s12967_024_05998_8
Genre Journal Article
Review
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: Anhui Province Scientific Research Staffing Plan Project
  grantid: AH050668
GroupedDBID ---
0R~
29L
2WC
53G
5VS
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
PPXIY
5PM
PJZUB
PUEGO
ID FETCH-LOGICAL-c536t-3c38cc9ffe205b1b7f8f12fcd820bbc63ff265f55dc97bcae5e84dadbc946e323
IEDL.DBID M48
ISSN 1479-5876
IngestDate Wed Aug 27 01:29:12 EDT 2025
Thu Aug 21 18:30:06 EDT 2025
Thu Jul 10 18:31:05 EDT 2025
Tue Jun 17 22:00:01 EDT 2025
Tue Jun 10 21:05:56 EDT 2025
Thu Apr 03 07:08:38 EDT 2025
Tue Jul 01 02:59:49 EDT 2025
Thu Apr 24 23:09:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Gastric carcinogenesis
miRNAs and lncRNAs
Targeted therapy and molecular inhibitors
Mitogen-activated protein kinase signaling
H. pylori and EBV-induced oncogenesis
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-3c38cc9ffe205b1b7f8f12fcd820bbc63ff265f55dc97bcae5e84dadbc946e323
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0009-0004-2686-6918
0000-0002-8211-6554
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12967-024-05998-8
PMID 39719645
PQID 3149070040
PQPubID 23479
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_1b8298b273704607ad7fc8400b8ac1ab
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11667996
proquest_miscellaneous_3149070040
gale_infotracmisc_A821228577
gale_infotracacademiconefile_A821228577
pubmed_primary_39719645
crossref_primary_10_1186_s12967_024_05998_8
crossref_citationtrail_10_1186_s12967_024_05998_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-12-24
PublicationDateYYYYMMDD 2024-12-24
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-12-24
  day: 24
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of translational medicine
PublicationTitleAlternate J Transl Med
PublicationYear 2024
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References L Cao (5998_CR57) 2022; 162
T Shi (5998_CR8) 2023; 235
G Jin (5998_CR28) 2020; 21
SZ Ding (5998_CR61) 2008; 23
Y Luo (5998_CR73) 2021; 21
T Wu (5998_CR109) 2023; 42
JL Martin (5998_CR149) 2001; 89
M Zhang (5998_CR32) 2022; 64
K Shoda (5998_CR9) 2017; 8
C Deng (5998_CR141) 2016; 7
S Nakonieczna (5998_CR147) 2020; 21
R-R Ma (5998_CR101) 2021; 40
RJ Huang (5998_CR51) 2023; 164
Z-H Chen (5998_CR71) 2021; 13
J Hu (5998_CR78) 2017; 141
X Liang (5998_CR156) 2021; 220
F Jiang (5998_CR42) 2019; 24
D Qiao (5998_CR146) 2021; 49
H Kuwahara (5998_CR58) 2000; 68
E Patrad (5998_CR72) 2022; 45
H Maadi (5998_CR163) 2021; 13
L Wu (5998_CR130) 2018; 11
B Zeng (5998_CR105) 2018; 18
R Fu (5998_CR129) 2019; 54
F Sun (5998_CR95) 2018; 9
MH Shin (5998_CR153) 2020; 21
Z Wang (5998_CR26) 2022; 71
N Ronkina (5998_CR155) 2022; 91
GS Wong (5998_CR38) 2018; 24
P Zhang (5998_CR137) 2023; 14
J Pandian (5998_CR83) 2022; 410
D Dai (5998_CR175) 2021; 12
M-F Pang (5998_CR76) 2009; 14
D-Y Oh (5998_CR164) 2020; 17
R Weissman (5998_CR87) 2022; 36
S Ariga (5998_CR171) 2023; 12
K Yang (5998_CR25) 2021; 15
J Zhang (5998_CR138) 2021; 141
M Wang (5998_CR178) 2023; 14
LL Li (5998_CR29) 2024; 169
T Olesiński (5998_CR117) 2021; 11
K Gala (5998_CR165) 2014; 20
Q Zhang (5998_CR121) 2021; 143
AB Dohlman (5998_CR173) 2022; 185
GR Zhou (5998_CR122) 2020; 24
Y Lu (5998_CR139) 2022; 23
P Katelaris (5998_CR18) 2023; 57
M Miftahussurur (5998_CR14) 2016; 2016
K Shitara (5998_CR166) 2016; 14
C Meng (5998_CR174) 2018; 16
CX Qu (5998_CR124) 2019; 23
Z Paroo (5998_CR85) 2009; 139
X Wang (5998_CR132) 2019; 25
B Damania (5998_CR68) 2022; 185
L Miao (5998_CR160) 2020; 28
C Ricci (5998_CR19) 2007; 21
AP Thrift (5998_CR47) 2023; 20
J Yang (5998_CR81) 2020; 495
H Cai (5998_CR21) 2016; 45
JF Li (5998_CR125) 2019; 23
S Yu (5998_CR89) 2010; 70
M Selbach (5998_CR62) 2009; 5
J Liu (5998_CR88) 2010; 285
V Haller (5998_CR152) 2020; 30
M Cargnello (5998_CR31) 2011; 75
C Korzeniecki (5998_CR151) 2021; 211
D-T Morgos (5998_CR162) 2024; 25
H Kim (5998_CR40) 2024; 166
J Ouyang (5998_CR45) 2021; 58
Q-H Qin (5998_CR97) 2018; 97
J Shen (5998_CR145) 2016; 81
MJ López (5998_CR3) 2023; 181
Y Xin (5998_CR116) 2016; 49
M Guardamagna (5998_CR182) 2022; 23
C-C Chen (5998_CR176) 2021; 13
D-L Chen (5998_CR94) 2021; 20
ST Kim (5998_CR69) 2018; 24
J Mu (5998_CR142) 2019; 120
D Li (5998_CR131) 2018; 22
Y Guo (5998_CR177) 2020; 69
J-X Zhang (5998_CR100) 2022; 21
F-Y Liu (5998_CR104) 2016; 5
T Matsuda (5998_CR22) 2013; 43
Y Fang (5998_CR179) 2021; 12
Cancer Genome Atlas Research, N (5998_CR82) 2014; 513
YC Chen (5998_CR50) 2024; 166
KS Abdelrahman (5998_CR161) 2021; 73
Y Mi (5998_CR102) 2017; 389
Z Gu (5998_CR144) 2020; 19
L Liu (5998_CR65) 2018; 18
L Xu (5998_CR103) 2017; 8
Z Song (5998_CR157) 2021; 11
H Sung (5998_CR2) 2021; 71
KU Birkenkamp (5998_CR150) 2000; 131
L Yu (5998_CR140) 2024; 326
JA Ajani (5998_CR1) 2022; 20
L-Y Zhao (5998_CR172) 2023; 8
L Costa (5998_CR11) 2024; 33
F Duan (5998_CR27) 2021; 13
X Li (5998_CR96) 2022; 93
T Seidlitz (5998_CR35) 2022; 14
A Ali (5998_CR4) 2024; 12
B Chen (5998_CR39) 2021; 20
H Mimuro (5998_CR63) 2002; 10
HM Stern (5998_CR170) 2012; 4
GB Park (5998_CR77) 2014; 44
T Phan (5998_CR34) 2023; 30
M Sun (5998_CR112) 2014; 13
P Cao (5998_CR5) 2017; 17
P Li (5998_CR127) 2016; 8
J He (5998_CR60) 2022; 542
Y Hirata (5998_CR70) 2023; 20
Y Yang (5998_CR154) 2014; 2014
K Arnauts (5998_CR180) 2022; 14
X Pan (5998_CR158) 2022; 12
T-P Xu (5998_CR119) 2017; 8
G Dahlen (5998_CR15) 2018; 18
L Ouyang (5998_CR135) 2023; 37
5998_CR17
MC Bridges (5998_CR107) 2021; 220
T Shimoyama (5998_CR12) 2013; 19
Y Li (5998_CR126) 2018; 208
M Ferwana (5998_CR10) 2015; 21
A Takahashi-Kanemitsu (5998_CR54) 2020; 17
MA Abd Rahim (5998_CR13) 2019; 85
RM Jones (5998_CR181) 2017; 105
J-B Xie (5998_CR99) 2023; 18
K Zhang (5998_CR113) 2017; 7
L Ma (5998_CR98) 2024; 334
N-R Choi (5998_CR143) 2024; 16
M Miftahussurur (5998_CR16) 2017; 19
PH Braz-Silva (5998_CR6) 2014; 25
L Wang (5998_CR79) 2021; 13
L Magnelli (5998_CR64) 2020; 21
H Zhang (5998_CR128) 2019; 11
I Sharafutdinov (5998_CR56) 2023; 31
C Röcken (5998_CR30) 2023; 149
Z Xu (5998_CR136) 2018; 51
F De Vita (5998_CR167) 2010; 36
M Drosten (5998_CR33) 2020; 37
H Razavi (5998_CR118) 2022; 23
SM Johnson (5998_CR86) 2005; 120
Y Sun (5998_CR93) 2020; 11
Y-Q Deng (5998_CR148) 2024; 123
T Yoshida (5998_CR67) 2022; 23
M Amieva (5998_CR48) 2016; 150
A Ahadi (5998_CR44) 2020; 72
Q Zhang (5998_CR134) 2020; 128
J-X Xiong (5998_CR36) 2024; 45
P Malfertheiner (5998_CR49) 2023; 9
Y Shi (5998_CR123) 2020; 13
BC Grieb (5998_CR169) 2021; 22
AC Anauate (5998_CR43) 2020; 21
SK Patel (5998_CR20) 2014; 20
W-X Peng (5998_CR108) 2017; 16
RA Pazo Cid (5998_CR168) 2013; 85
AB Herman (5998_CR106) 2022; 82
NY Chia (5998_CR24) 2016; 27
Y Hashimoto (5998_CR92) 2010; 31
C Barbagallo (5998_CR114) 2018; 12
JY Park (5998_CR55) 2018; 10
Q Liu (5998_CR66) 2022; 184
ME Hatley (5998_CR91) 2010; 18
AP Burke (5998_CR80) 1990; 3
H-L Li (5998_CR133) 2016; 14
Z-Y Yu (5998_CR37) 2020; 133
BM Hussen (5998_CR110) 2021; 9
Y Usui (5998_CR53) 2023; 388
K Sugano (5998_CR23) 2023; 165
CW Dawson (5998_CR74) 2012; 22
R Li (5998_CR111) 2014; 9
J-M Liou (5998_CR52) 2020; 69
L Fu (5998_CR159) 2022; 65
S Ghafouri-Fard (5998_CR46) 2020; 757
D Nkosi (5998_CR75) 2020; 11
M Xu (5998_CR84) 2023; 97
Z Gao (5998_CR120) 2022; 43
X Liu (5998_CR41) 2021; 42
TL Cover (5998_CR59) 2020; 28
C Zhang (5998_CR115) 2023; 42
SJ Na (5998_CR7) 2017; 31
GRL Al-Awsi (5998_CR90) 2022; 18
References_xml – volume: 131
  start-page: 99
  issue: 1
  year: 2000
  ident: 5998_CR150
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0703534
– volume: 30
  start-page: 453
  issue: 6
  year: 2020
  ident: 5998_CR152
  publication-title: Expert Opin Ther Pat
  doi: 10.1080/13543776.2020.1749263
– volume: 45
  start-page: 774
  issue: 3
  year: 2016
  ident: 5998_CR21
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyw078
– volume: 389
  start-page: 11
  year: 2017
  ident: 5998_CR102
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2016.12.033
– volume: 9
  issue: 6
  year: 2014
  ident: 5998_CR111
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0100893
– volume: 49
  start-page: 525
  issue: 2
  year: 2021
  ident: 5998_CR146
  publication-title: Am J Chin Med
  doi: 10.1142/S0192415X21500245
– volume: 45
  start-page: 405
  issue: 2
  year: 2024
  ident: 5998_CR36
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/s41401-023-01165-9
– volume: 23
  start-page: e67
  issue: 7 Pt 2
  year: 2008
  ident: 5998_CR61
  publication-title: J Gastroenterol Hepatol
– ident: 5998_CR17
– volume: 75
  start-page: 50
  issue: 1
  year: 2011
  ident: 5998_CR31
  publication-title: Microbiol Mol Biol Rev
  doi: 10.1128/MMBR.00031-10
– volume: 184
  year: 2022
  ident: 5998_CR66
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2022.106440
– volume: 13
  start-page: 21451
  issue: 17
  year: 2021
  ident: 5998_CR27
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.203484
– volume: 8
  issue: 6
  year: 2017
  ident: 5998_CR119
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.205
– volume: 20
  start-page: 167
  issue: 2
  year: 2022
  ident: 5998_CR1
  publication-title: J Natl Compr Cancer Netw JNCCN
  doi: 10.6004/jnccn.2022.0008
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  ident: 5998_CR2
  publication-title: CA A Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 85
  start-page: 110
  issue: 1
  year: 2019
  ident: 5998_CR13
  publication-title: Ann Glob Health
  doi: 10.5334/aogh.2570
– volume: 21
  start-page: 93
  issue: 1
  year: 2021
  ident: 5998_CR73
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-021-01793-3
– volume: 36
  start-page: 1139
  issue: 4
  year: 2022
  ident: 5998_CR87
  publication-title: Leukemia
  doi: 10.1038/s41375-021-01472-2
– volume: 8
  issue: 3
  year: 2017
  ident: 5998_CR103
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.5
– volume: 97
  issue: 9
  year: 2023
  ident: 5998_CR84
  publication-title: J Virol
  doi: 10.1128/jvi.00881-23
– volume: 69
  start-page: 1598
  issue: 9
  year: 2020
  ident: 5998_CR177
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-319696
– volume: 13
  start-page: 3540
  issue: 14
  year: 2021
  ident: 5998_CR163
  publication-title: Cancers
  doi: 10.3390/cancers13143540
– volume: 3
  start-page: 377
  issue: 3
  year: 1990
  ident: 5998_CR80
  publication-title: Mod Pathol
– volume: 334
  year: 2024
  ident: 5998_CR98
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2024.118538
– volume: 139
  start-page: 112
  issue: 1
  year: 2009
  ident: 5998_CR85
  publication-title: Cell
  doi: 10.1016/j.cell.2009.06.044
– volume: 51
  start-page: 58
  year: 2018
  ident: 5998_CR136
  publication-title: Phytomed Int J Phytother Phytopharmacol
– volume: 24
  start-page: 53
  year: 2019
  ident: 5998_CR42
  publication-title: Cell Mol Biol Lett
  doi: 10.1186/s11658-019-0178-5
– volume: 285
  start-page: 26599
  issue: 34
  year: 2010
  ident: 5998_CR88
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.115824
– volume: 21
  start-page: 1305
  issue: 4
  year: 2015
  ident: 5998_CR10
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v21.i4.1305
– volume: 5
  start-page: 397
  issue: 4
  year: 2009
  ident: 5998_CR62
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2009.03.004
– volume: 22
  start-page: 88
  issue: 10
  year: 2021
  ident: 5998_CR169
  publication-title: Curr Treat Options Oncol
  doi: 10.1007/s11864-021-00884-7
– volume: 162
  start-page: 1716
  issue: 6
  year: 2022
  ident: 5998_CR57
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2022.01.046
– volume: 220
  issue: 2
  year: 2021
  ident: 5998_CR107
  publication-title: J Cell Biol
  doi: 10.1083/jcb.202009045
– volume: 71
  start-page: 2391
  issue: 12
  year: 2022
  ident: 5998_CR26
  publication-title: Gut
  doi: 10.1136/gutjnl-2021-325948
– volume: 21
  start-page: 227
  issue: 1
  year: 2022
  ident: 5998_CR100
  publication-title: Mol Cancer
  doi: 10.1186/s12943-022-01702-w
– volume: 166
  start-page: 605
  issue: 4
  year: 2024
  ident: 5998_CR50
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2023.12.022
– volume: 16
  start-page: 33
  issue: 1
  year: 2018
  ident: 5998_CR174
  publication-title: Genomics Proteomics Bioinform
  doi: 10.1016/j.gpb.2017.06.002
– volume: 23
  start-page: 352
  issue: 1
  year: 2022
  ident: 5998_CR118
  publication-title: BMC Genomics
  doi: 10.1186/s12864-022-08578-6
– volume: 23
  start-page: 1
  issue: 1
  year: 2022
  ident: 5998_CR139
  publication-title: J Zhejiang Univ Sci B
  doi: 10.1631/jzus.B2100182
– volume: 149
  start-page: 467
  issue: 1
  year: 2023
  ident: 5998_CR30
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-022-04408-0
– volume: 97
  start-page: 450
  year: 2018
  ident: 5998_CR97
  publication-title: Biomed Pharmacother Biomed Pharmacother
  doi: 10.1016/j.biopha.2017.10.066
– volume: 14
  start-page: 1282203
  year: 2023
  ident: 5998_CR137
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2023.1282203
– volume: 169
  start-page: 114
  issue: 5
  year: 2024
  ident: 5998_CR29
  publication-title: Arch Virol
  doi: 10.1007/s00705-024-06033-3
– volume: 21
  start-page: 2531
  issue: 7
  year: 2020
  ident: 5998_CR153
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21072531
– volume: 36
  start-page: S11
  issue: Suppl 3
  year: 2010
  ident: 5998_CR167
  publication-title: Cancer Treat Rev
  doi: 10.1016/S0305-7372(10)70014-1
– volume: 70
  start-page: 6015
  issue: 14
  year: 2010
  ident: 5998_CR89
  publication-title: Can Res
  doi: 10.1158/0008-5472.CAN-09-4531
– volume: 185
  start-page: 3652
  issue: 20
  year: 2022
  ident: 5998_CR68
  publication-title: Cell
  doi: 10.1016/j.cell.2022.08.026
– volume: 9
  start-page: 19
  issue: 1
  year: 2023
  ident: 5998_CR49
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-023-00431-8
– volume: 22
  start-page: 144
  issue: 2
  year: 2012
  ident: 5998_CR74
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2012.01.004
– volume: 208
  start-page: 295
  year: 2018
  ident: 5998_CR126
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2018.07.032
– volume: 19
  start-page: 8188
  issue: 45
  year: 2013
  ident: 5998_CR12
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v19.i45.8188
– volume: 24
  start-page: 968
  issue: 7
  year: 2018
  ident: 5998_CR38
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0022-x
– volume: 25
  start-page: 3128
  issue: 10
  year: 2019
  ident: 5998_CR132
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-2804
– volume: 120
  start-page: 635
  issue: 5
  year: 2005
  ident: 5998_CR86
  publication-title: Cell
  doi: 10.1016/j.cell.2005.01.014
– volume: 120
  start-page: 1011
  issue: 1
  year: 2019
  ident: 5998_CR142
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.27542
– volume: 24
  start-page: 3657
  issue: 7
  year: 2020
  ident: 5998_CR122
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 28
  start-page: 154
  issue: 2
  year: 2020
  ident: 5998_CR160
  publication-title: J Drug Target
  doi: 10.1080/1061186X.2019.1648477
– volume: 14
  issue: 10
  year: 2022
  ident: 5998_CR35
  publication-title: EMBO Mol Med
  doi: 10.15252/emmm.202215705
– volume: 89
  start-page: 750
  issue: 9
  year: 2001
  ident: 5998_CR149
  publication-title: Circ Res
  doi: 10.1161/hh2101.099504
– volume: 31
  start-page: 749
  issue: 4
  year: 2017
  ident: 5998_CR7
  publication-title: In Vivo
  doi: 10.21873/invivo.11126
– volume: 27
  start-page: 763
  issue: 5
  year: 2016
  ident: 5998_CR24
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdw040
– volume: 91
  start-page: 505
  year: 2022
  ident: 5998_CR155
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev-biochem-081720-114505
– volume: 8
  start-page: 28796
  issue: 17
  year: 2017
  ident: 5998_CR9
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.15675
– volume: 7
  issue: 2
  year: 2016
  ident: 5998_CR141
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2016.13
– volume: 18
  start-page: 5733
  issue: 6
  year: 2018
  ident: 5998_CR65
  publication-title: Mol Med Rep
– volume: 11
  start-page: 15369
  issue: 1
  year: 2021
  ident: 5998_CR117
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-94576-9
– volume: 9
  year: 2021
  ident: 5998_CR110
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2021.689992
– volume: 165
  start-page: 1352
  issue: 6
  year: 2023
  ident: 5998_CR23
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2023.08.028
– volume: 105
  start-page: 41
  year: 2017
  ident: 5998_CR181
  publication-title: Free Radical Biol Med
  doi: 10.1016/j.freeradbiomed.2016.10.495
– volume: 14
  start-page: 222
  issue: 2
  year: 2009
  ident: 5998_CR76
  publication-title: Cell Mol Biol Lett
  doi: 10.2478/s11658-008-0045-2
– volume: 17
  start-page: 323
  issue: 1
  year: 2017
  ident: 5998_CR5
  publication-title: BMC Infect Dis
  doi: 10.1186/s12879-017-2412-y
– volume: 19
  start-page: 153473542095321
  year: 2020
  ident: 5998_CR144
  publication-title: Integr Cancer Ther
  doi: 10.1177/1534735420953215
– volume: 17
  start-page: 50
  issue: 1
  year: 2020
  ident: 5998_CR54
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-019-0339-5
– volume: 150
  start-page: 64
  issue: 1
  year: 2016
  ident: 5998_CR48
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2015.09.004
– volume: 57
  start-page: 111
  issue: 2
  year: 2023
  ident: 5998_CR18
  publication-title: J Clin Gastroenterol
  doi: 10.1097/MCG.0000000000001719
– volume: 495
  start-page: 191
  year: 2020
  ident: 5998_CR81
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2020.09.019
– volume: 410
  issue: 1
  year: 2022
  ident: 5998_CR83
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2021.112956
– volume: 11
  start-page: 13
  issue: 1
  year: 2021
  ident: 5998_CR157
  publication-title: Acta Pharmaceutica Sinica B
  doi: 10.1016/j.apsb.2020.07.010
– volume: 49
  start-page: 255
  issue: 3
  year: 2016
  ident: 5998_CR116
  publication-title: Cell Prolif
  doi: 10.1111/cpr.12252
– volume: 37
  start-page: 543
  issue: 4
  year: 2020
  ident: 5998_CR33
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2020.03.013
– volume: 20
  start-page: 338
  issue: 5
  year: 2023
  ident: 5998_CR47
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-023-00747-0
– volume: 17
  start-page: 33
  issue: 1
  year: 2020
  ident: 5998_CR164
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-019-0268-3
– volume: 82
  start-page: 2252
  issue: 12
  year: 2022
  ident: 5998_CR106
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2022.05.027
– volume: 235
  start-page: 221
  issue: 4
  year: 2023
  ident: 5998_CR8
  publication-title: Klin Padiatr
  doi: 10.1055/a-2041-2986
– volume: 18
  start-page: 34
  issue: 1
  year: 2018
  ident: 5998_CR105
  publication-title: BMC Cancer
  doi: 10.1186/s12885-017-3949-2
– volume: 11
  issue: 3
  year: 2020
  ident: 5998_CR75
  publication-title: MBio
  doi: 10.1128/mBio.00589-20
– volume: 11
  start-page: 4631
  year: 2018
  ident: 5998_CR130
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S168819
– volume: 8
  start-page: 201
  issue: 1
  year: 2023
  ident: 5998_CR172
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-023-01406-7
– volume: 12
  start-page: 720
  issue: 1
  year: 2021
  ident: 5998_CR179
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.1889109
– volume: 31
  start-page: 1345
  issue: 8
  year: 2023
  ident: 5998_CR56
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2023.06.016
– volume: 513
  start-page: 202
  issue: 7517
  year: 2014
  ident: 5998_CR82
  publication-title: Nature
  doi: 10.1038/nature13480
– volume: 85
  start-page: 350
  issue: 3
  year: 2013
  ident: 5998_CR168
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/j.critrevonc.2012.08.008
– volume: 21
  start-page: 2893
  issue: 8
  year: 2020
  ident: 5998_CR64
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21082893
– volume: 4
  start-page: 12rv72
  issue: 127
  year: 2012
  ident: 5998_CR170
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3001539
– volume: 11
  start-page: 8589
  year: 2019
  ident: 5998_CR128
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S186002
– volume: 2016
  start-page: 4819423
  year: 2016
  ident: 5998_CR14
  publication-title: Biomed Res Int
  doi: 10.1155/2016/4819423
– volume: 45
  start-page: 1073
  issue: 6
  year: 2022
  ident: 5998_CR72
  publication-title: Cell Oncol (Dordr)
  doi: 10.1007/s13402-022-00715-3
– volume: 43
  start-page: 1157
  issue: 11
  year: 2013
  ident: 5998_CR22
  publication-title: Jpn J Clin Oncol
  doi: 10.1093/jjco/hyt166
– volume: 11
  start-page: 836
  issue: 10
  year: 2020
  ident: 5998_CR93
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-020-03049-w
– volume: 8
  start-page: 3522
  issue: 8
  year: 2016
  ident: 5998_CR127
  publication-title: Am J Transl Res
– volume: 18
  start-page: 282
  issue: 3
  year: 2010
  ident: 5998_CR91
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2010.08.013
– volume: 42
  start-page: 14
  issue: 1
  year: 2023
  ident: 5998_CR109
  publication-title: J Exp Clin Cancer Res CR
  doi: 10.1186/s13046-022-02588-8
– volume: 65
  start-page: 13561
  issue: 20
  year: 2022
  ident: 5998_CR159
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.2c01244
– volume: 68
  start-page: 4378
  issue: 8
  year: 2000
  ident: 5998_CR58
  publication-title: Infect Immun
  doi: 10.1128/IAI.68.8.4378-4383.2000
– volume: 28
  start-page: 682
  issue: 8
  year: 2020
  ident: 5998_CR59
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2020.02.004
– volume: 13
  start-page: 146
  issue: 1
  year: 2021
  ident: 5998_CR71
  publication-title: Genome Medicine
  doi: 10.1186/s13073-021-00963-2
– volume: 31
  start-page: 777
  issue: 5
  year: 2010
  ident: 5998_CR92
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgq013
– volume: 24
  start-page: 1449
  issue: 9
  year: 2018
  ident: 5998_CR69
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0101-z
– volume: 16
  start-page: 161
  issue: 1
  year: 2017
  ident: 5998_CR108
  publication-title: Mol Cancer
  doi: 10.1186/s12943-017-0727-3
– volume: 21
  start-page: 299
  issue: 2
  year: 2007
  ident: 5998_CR19
  publication-title: Best Pract Res Clin Gastroenterol
  doi: 10.1016/j.bpg.2006.11.002
– volume: 388
  start-page: 1181
  issue: 13
  year: 2023
  ident: 5998_CR53
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2211807
– volume: 58
  start-page: 7
  issue: 4
  year: 2021
  ident: 5998_CR45
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2021.5187
– volume: 40
  start-page: 2524
  issue: 14
  year: 2021
  ident: 5998_CR101
  publication-title: Oncogene
  doi: 10.1038/s41388-020-01610-7
– volume: 10
  start-page: 163
  issue: 4
  year: 2018
  ident: 5998_CR55
  publication-title: Toxins
  doi: 10.3390/toxins10040163
– volume: 44
  start-page: 977
  issue: 3
  year: 2014
  ident: 5998_CR77
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2014.2252
– volume: 42
  start-page: 246
  issue: 1
  year: 2023
  ident: 5998_CR115
  publication-title: J Exp Clin Cancer Res CR
  doi: 10.1186/s13046-023-02827-6
– volume: 13
  start-page: 68
  year: 2014
  ident: 5998_CR112
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-13-68
– volume: 12
  start-page: 1104
  issue: 12
  year: 2021
  ident: 5998_CR175
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-021-04396-y
– volume: 20
  start-page: 166
  issue: 1
  year: 2021
  ident: 5998_CR94
  publication-title: Mol Cancer
  doi: 10.1186/s12943-021-01475-8
– volume: 23
  start-page: 588
  issue: 2
  year: 2019
  ident: 5998_CR125
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 12
  start-page: 2171
  issue: 5
  year: 2022
  ident: 5998_CR158
  publication-title: Acta Pharmaceutica Sinica B
  doi: 10.1016/j.apsb.2021.12.022
– volume: 18
  start-page: 89
  issue: 1
  year: 2018
  ident: 5998_CR15
  publication-title: BMC Oral Health
  doi: 10.1186/s12903-018-0541-3
– volume: 18
  start-page: 20230776
  issue: 1
  year: 2023
  ident: 5998_CR99
  publication-title: Open Med (Warsaw, Poland)
  doi: 10.1515/med-2023-0776
– volume: 54
  start-page: 1545
  issue: 5
  year: 2019
  ident: 5998_CR129
  publication-title: Int J Oncol
– volume: 21
  start-page: 8307
  issue: 21
  year: 2020
  ident: 5998_CR147
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21218307
– volume: 42
  start-page: 1018
  issue: 7
  year: 2021
  ident: 5998_CR41
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/s41401-020-00540-0
– volume: 23
  start-page: 8852
  issue: 20
  year: 2019
  ident: 5998_CR124
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 141
  start-page: 111876
  year: 2021
  ident: 5998_CR138
  publication-title: Biomed Pharmacother Biomed Pharmacother
  doi: 10.1016/j.biopha.2021.111876
– volume: 133
  start-page: 919
  issue: 8
  year: 2020
  ident: 5998_CR37
  publication-title: Chin Med J
  doi: 10.1097/CM9.0000000000000742
– volume: 14
  start-page: 1313
  issue: 10
  year: 2016
  ident: 5998_CR166
  publication-title: J Natl Compr Cancer Netw JNCCN
  doi: 10.6004/jnccn.2016.0138
– volume: 5
  start-page: 2302
  issue: 9
  year: 2016
  ident: 5998_CR104
  publication-title: Cancer Med
  doi: 10.1002/cam4.818
– volume: 166
  start-page: 117
  issue: 1
  year: 2024
  ident: 5998_CR40
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2023.09.040
– volume: 69
  start-page: 2093
  issue: 12
  year: 2020
  ident: 5998_CR52
  publication-title: Gut
  doi: 10.1136/gutjnl-2020-322368
– volume: 10
  start-page: 745
  issue: 4
  year: 2002
  ident: 5998_CR63
  publication-title: Mol Cell
  doi: 10.1016/S1097-2765(02)00681-0
– volume: 37
  start-page: 689
  issue: 2
  year: 2023
  ident: 5998_CR135
  publication-title: Phytother Res PTR
  doi: 10.1002/ptr.7652
– volume: 72
  start-page: 884
  issue: 5
  year: 2020
  ident: 5998_CR44
  publication-title: IUBMB Life
  doi: 10.1002/iub.2259
– volume: 81
  start-page: 120
  year: 2016
  ident: 5998_CR145
  publication-title: Biomed Pharmacother Biomed Pharmacother
  doi: 10.1016/j.biopha.2016.03.046
– volume: 542
  year: 2022
  ident: 5998_CR60
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2022.215764
– volume: 13
  start-page: 5451
  issue: 21
  year: 2021
  ident: 5998_CR79
  publication-title: Cancers
  doi: 10.3390/cancers13215451
– volume: 43
  start-page: 419
  issue: 5
  year: 2022
  ident: 5998_CR120
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgac018
– volume: 13
  start-page: 2115
  year: 2020
  ident: 5998_CR123
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S217452
– volume: 9
  start-page: 522
  issue: 5
  year: 2018
  ident: 5998_CR95
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-018-0611-0
– volume: 14
  start-page: 1183331
  year: 2023
  ident: 5998_CR178
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2023.1183331
– volume: 21
  start-page: 1782
  issue: 5
  year: 2020
  ident: 5998_CR43
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21051782
– volume: 93
  year: 2022
  ident: 5998_CR96
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2022.110286
– volume: 128
  year: 2020
  ident: 5998_CR134
  publication-title: Biomed Pharmacother Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.110245
– volume: 12
  start-page: 222
  issue: 1
  year: 2024
  ident: 5998_CR4
  publication-title: Microorganisms
  doi: 10.3390/microorganisms12010222
– volume: 14
  start-page: 1430
  issue: 2
  year: 2016
  ident: 5998_CR133
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2016.5361
– volume: 757
  year: 2020
  ident: 5998_CR46
  publication-title: Gene
  doi: 10.1016/j.gene.2020.144937
– volume: 16
  start-page: 965
  issue: 7
  year: 2024
  ident: 5998_CR143
  publication-title: Nutrients
  doi: 10.3390/nu16070965
– volume: 2014
  year: 2014
  ident: 5998_CR154
  publication-title: Mediat Inflamm
  doi: 10.1155/2014/352371
– volume: 13
  start-page: 1909459
  issue: 1
  year: 2021
  ident: 5998_CR176
  publication-title: Gut Microbes
  doi: 10.1080/19490976.2021.1909459
– volume: 18
  start-page: 4209
  issue: 38
  year: 2022
  ident: 5998_CR90
  publication-title: Future Oncol (London, England)
  doi: 10.2217/fon-2022-0574
– volume: 73
  start-page: 405
  issue: 2
  year: 2021
  ident: 5998_CR161
  publication-title: Pharmacol Rep PR
  doi: 10.1007/s43440-021-00238-y
– volume: 14
  start-page: 2089003
  issue: 1
  year: 2022
  ident: 5998_CR180
  publication-title: Gut Microbes
  doi: 10.1080/19490976.2022.2089003
– volume: 25
  start-page: 21
  issue: 1
  year: 2014
  ident: 5998_CR6
  publication-title: Cytopathology
  doi: 10.1111/cyt.12053
– volume: 20
  start-page: 453
  issue: 7
  year: 2023
  ident: 5998_CR70
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-023-00767-w
– volume: 141
  start-page: 1722
  issue: 9
  year: 2017
  ident: 5998_CR78
  publication-title: Int J Cancer
  doi: 10.1002/ijc.30816
– volume: 181
  year: 2023
  ident: 5998_CR3
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/j.critrevonc.2022.103841
– volume: 20
  start-page: 1410
  issue: 6
  year: 2014
  ident: 5998_CR165
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-13-1549
– volume: 33
  start-page: 173
  issue: 3
  year: 2024
  ident: 5998_CR11
  publication-title: Med Princ Pract
  doi: 10.1159/000538349
– volume: 123
  year: 2024
  ident: 5998_CR148
  publication-title: Phytomed Int J Phytother Phytopharmacol
– volume: 19
  year: 2017
  ident: 5998_CR16
  publication-title: Expert Rev Mol Med
  doi: 10.1017/erm.2017.4
– volume: 21
  start-page: 1378
  issue: 10
  year: 2020
  ident: 5998_CR28
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(20)30460-5
– volume: 23
  start-page: 191
  issue: 1
  year: 2022
  ident: 5998_CR67
  publication-title: Cancer Biol Ther
  doi: 10.1080/15384047.2022.2038002
– volume: 20
  start-page: 147
  issue: 1
  year: 2021
  ident: 5998_CR39
  publication-title: Mol Cancer
  doi: 10.1186/s12943-021-01451-2
– volume: 326
  year: 2024
  ident: 5998_CR140
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2024.117988
– volume: 23
  start-page: 11990
  issue: 19
  year: 2022
  ident: 5998_CR182
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms231911990
– volume: 164
  start-page: 736
  issue: 5
  year: 2023
  ident: 5998_CR51
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2023.01.018
– volume: 15
  start-page: 255
  issue: 3
  year: 2021
  ident: 5998_CR25
  publication-title: Expert Rev Gastroenterol Hepatol
  doi: 10.1080/17474124.2021.1845140
– volume: 185
  start-page: 3807
  issue: 20
  year: 2022
  ident: 5998_CR173
  publication-title: Cell
  doi: 10.1016/j.cell.2022.09.015
– volume: 64
  start-page: 301
  issue: 2
  year: 2022
  ident: 5998_CR32
  publication-title: J Integr Plant Biol
  doi: 10.1111/jipb.13215
– volume: 22
  start-page: 3875
  issue: 8
  year: 2018
  ident: 5998_CR131
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.13661
– volume: 12
  start-page: 229
  year: 2018
  ident: 5998_CR114
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2018.05.009
– volume: 7
  start-page: 213
  issue: 1
  year: 2017
  ident: 5998_CR113
  publication-title: Theranostics
  doi: 10.7150/thno.16044
– volume: 30
  start-page: 1181
  issue: 9
  year: 2023
  ident: 5998_CR34
  publication-title: Cancer Gene Ther
  doi: 10.1038/s41417-023-00622-1
– volume: 211
  year: 2021
  ident: 5998_CR151
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2020.113006
– volume: 220
  year: 2021
  ident: 5998_CR156
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2021.113473
– volume: 143
  start-page: 112235
  year: 2021
  ident: 5998_CR121
  publication-title: Biomed Pharmacother Biomed Pharmacother
  doi: 10.1016/j.biopha.2021.112235
– volume: 25
  start-page: 1848
  issue: 3
  year: 2024
  ident: 5998_CR162
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms25031848
– volume: 20
  start-page: 12847
  issue: 36
  year: 2014
  ident: 5998_CR20
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v20.i36.12847
– volume: 12
  start-page: 3991
  issue: 10
  year: 2023
  ident: 5998_CR171
  publication-title: J Clin Med
  doi: 10.3390/jcm12103391
SSID ssj0024549
Score 2.4614322
SecondaryResourceType review_article
Snippet Gastric cancer remains a significant health burden globally, especially prevalent in Asian and European regions. Despite a notable decline in incidence in the...
Abstract Gastric cancer remains a significant health burden globally, especially prevalent in Asian and European regions. Despite a notable decline in...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1142
SubjectTerms Analysis
Animals
Care and treatment
Diagnosis
Extracellular signal-regulated kinases
Gastric carcinogenesis
H. pylori and EBV-induced oncogenesis
Health aspects
Humans
MAP Kinase Signaling System
MicroRNAs - genetics
MicroRNAs - metabolism
miRNAs and lncRNAs
Mitogen-activated protein kinase signaling
Molecular dynamics
Review
Stomach cancer
Stomach Neoplasms - genetics
Stomach Neoplasms - metabolism
Stomach Neoplasms - pathology
Stomach Neoplasms - therapy
Targeted therapy and molecular inhibitors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yB_Eivm1dJYLgQZrtpDuP9jaKy6KMeHBhbyGpJDq49sjOjOK_t6ofwzSCXrwm6aY6VZWq6lR9xdjznMjLaFUposhlk1AVbTKxjBJi3UKI0LdOWH7QZ-fNuwt1cdDqi3LCBnjgYeNORLCytQGtrKE7POOjyYBRSRWsB-EDnb5o86ZgakLZw7BnKpGx-mSDVg2pwPGS8EhsaWdmqEfr__NMPjBK84TJAwt0eovdHF1HvhhIvs2upe4Ou74cL8fvMkCWc8oW5OvMl4uP7zm1G_7pf_FVxz97atABHIjLV6_4rvuRVlSKzr9NDXJ5Tyo641-57yI_qMziSGtfkrm5x85P3356c1aOPRRKULXeljXUFqDNOclKBRFMtlnIDBEtfwig65ylVlmpCK0J4JNKtok-BmgbnWpZ32dH3bpLDxmn_6VVi_4NWN_o4G2bDDpoIBS-p6qhYGLaUgcjwDj1ubh0faBhtRvY4JANrmeDswV7uX_m-wCv8dfVr4lT-5UEjd0PoMC4UWDcvwSmYC-Iz44UGMkDP9Yh4EcSFJZbWLTm0ipjCnY8W4mKB7PpZ5OkOJqibLUurXcbV2PYWVHfgKpgDwbJ2dOM_h9hoKmC2ZlMzT5qPtOtvvS430JobTA-ffQ_tuExuyFJH4QsZXPMjrZXu_QE_atteNqr0m-FtiJ6
  priority: 102
  providerName: Directory of Open Access Journals
Title The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects
URI https://www.ncbi.nlm.nih.gov/pubmed/39719645
https://www.proquest.com/docview/3149070040
https://pubmed.ncbi.nlm.nih.gov/PMC11667996
https://doaj.org/article/1b8298b273704607ad7fc8400b8ac1ab
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEA_3AeKL-H3Vc4kg-CDVpm2aVBDZlTsOZY_jcGHxJSST5Fw8u7of6v33TrLddYuH-NKHJm3TzExnJs38foQ88y5EGTVPmWU-LR2aonTCpjYHW9RgLETqhOFpdTIq34_5eIes6Y7aCZxfm9oFPqnR7PLlr-9Xb9Hg30SDl9WrOfosfAZ6mzSgjchU7pJ99EwiGOqwlH-w93gMh1kp6pTjZ2BdRHPtPTqOKuL5__3V3nJb3S2VWz7q-Da51QaXtL_ShjtkxzV3yY1h-_v8HgFUChr2E9Kpp8P-2QcaCIl_6is6aeiFDhQeQCHowew1XTY_3CQUq9OvawpdGoeKM_WF6sbSrdotimONRZvz-2R0fPTx3UnasiykwItqkRZQSIDae5dn3DAjvPQs92AxNjAGqsL7vOKecwu1MKAdd7K02hqoy8oVefGA7DXTxh0QGlZUsxojIJC6rIyWtRMYwgHjeJ-sgISw9ZQqaCHIAxPGpYqpiKzUSgwKxaCiGJRMyIvNNd9WABz_7D0Iktr0DODZ8cR0dqFaW1TMyLyWBgM3EX4LC22FB0x0MyM1MG0S8jzIWQWlw-GBbisV8CUDWJbqS_T3ueRCJOSw0xNNEzrNT9eaokJT2M_WuOlyrgpMTLPALJAl5OFKczZjxggxoKTxhMiOTnVeqtvSTD5HZHDGqkpgBvvoPx78mNzMg7qzPM3LQ7K3mC3dEwywFqZHdsVY9Mj-4Oj07LwXlyl60ZLweD749Bs4ziYI
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+MAPK+pathway+in+gastric+cancer%3A+unveiling+molecular+crosstalk+and+therapeutic+prospects&rft.jtitle=Journal+of+translational+medicine&rft.au=Yuan%2C+Weiwei&rft.au=Shi%2C+Yin&rft.au=Dai%2C+Shiping&rft.au=Deng%2C+Mao&rft.date=2024-12-24&rft.issn=1479-5876&rft.eissn=1479-5876&rft.volume=22&rft.issue=1&rft.spage=1142&rft_id=info:doi/10.1186%2Fs12967-024-05998-8&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon